SE0100297D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0100297D0
SE0100297D0 SE0100297A SE0100297A SE0100297D0 SE 0100297 D0 SE0100297 D0 SE 0100297D0 SE 0100297 A SE0100297 A SE 0100297A SE 0100297 A SE0100297 A SE 0100297A SE 0100297 D0 SE0100297 D0 SE 0100297D0
Authority
SE
Sweden
Prior art keywords
new compounds
relates
present
compounds
methylbenzylamino
Prior art date
Application number
SE0100297A
Other languages
Swedish (sv)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0100297A priority Critical patent/SE0100297D0/en
Publication of SE0100297D0 publication Critical patent/SE0100297D0/en
Priority to PCT/SE2002/000162 priority patent/WO2002060440A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Abstract

The present invention relates to novel crystalline forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo[1,2-a]pyridine-6-carboxamide. Further, the present invention also relates to use of said compounds for the treatment of gastrointestinal disorders, pharmaceutical compositions containing them and processes for obtaining them.
SE0100297A 2001-02-01 2001-02-01 New compounds SE0100297D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0100297A SE0100297D0 (en) 2001-02-01 2001-02-01 New compounds
PCT/SE2002/000162 WO2002060440A1 (en) 2001-02-01 2002-01-30 Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100297A SE0100297D0 (en) 2001-02-01 2001-02-01 New compounds

Publications (1)

Publication Number Publication Date
SE0100297D0 true SE0100297D0 (en) 2001-02-01

Family

ID=20282799

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100297A SE0100297D0 (en) 2001-02-01 2001-02-01 New compounds

Country Status (2)

Country Link
SE (1) SE0100297D0 (en)
WO (1) WO2002060440A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050086584A (en) 2002-11-19 2005-08-30 알타나 파마 아게 8-substituted imidazopyridines
CN1874772A (en) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (en) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
WO2007043938A1 (en) * 2005-10-07 2007-04-19 Astrazeneca Ab NOVEL CRYSTALLINE FORM OF 3,5-DIBROMO-N- [ (2S) -2- (-4- FLUOROPHENYL) -4- (3-MORPHOLIN-4-YLAZTIDIN-l-YL) BUTYL] -N METHYLBENZAMIDE, MODIFICATION B

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801526D0 (en) * 1998-04-29 1998-04-29 Astra Ab New compounds

Also Published As

Publication number Publication date
WO2002060440A1 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
PT1625126E (en) Imidazo and thiazolopyridines as jak3 kinase inhibitors
WO2003095455A3 (en) Substituted pyrazolopyrimidines
WO2006107771A3 (en) PYRAZOLO[3,4-c]QUINOLINES, PYRAZOLO[3,4-c]NAPHTHYRIDINES, ANALOGS THEREOF, AND METHODS
ATE301653T1 (en) PYRAZOLOPYRIDINES
AP2005003424A0 (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders; process for their preparation and pharmaceutical compositions containing them.
MX2007000044A (en) Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d ]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use.
GB0111186D0 (en) Novel compounds
SI1730144T1 (en) Substituted 1,4,8-triazaspiro 4.5 decan-2-one compounds
WO2002048148A3 (en) Pyrazolopyridine derivatives
SE9904129D0 (en) Novel compounds
MY128241A (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
PL366858A1 (en) Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments
EE200100377A (en) Use of Imidazo [1,5-a] -pyrido [3,2-e] -pyrazinones as Medicines
WO2005055939A3 (en) Vinca derivatives
WO2005055943A3 (en) Vinorelbine derivatives
SE9802574D0 (en) Novel compounds
SE0100297D0 (en) New compounds
SE0100296D0 (en) New compounds
SE0100295D0 (en) New compounds
CA2445189A1 (en) Carboline derivatives as pdev inhibitors
HUP0103912A3 (en) Substituted alkylpyridazinone derivatives, process for their preparation, their use for the preparation of pharmaceutical compositions with anxiolytic activity
MXPA03008894A (en) Use of substituted imidazo[1,2-a]-pyridine-3-yl-amide and imidazo[1,2-a]-pyridine-3-yl-amine compounds as medicaments.
DE60111553D1 (en) HEXAHYDROPYRAZINO [1'2 ': 1,6] -PYRIDO [3,4-B] INDOLE-1,4-DION DERIVATIVES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND ERROR DISORDERS
SE0303451D0 (en) New compounds
HRP20050790A2 (en) New combinations and new use of selected pharmaceutically active compounds